Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy-Reference-Cited by-同舟云学术

Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy

Published:2013-12-12 Issue:4 Volume:13 Page:612-621
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Meregalli Cristina,Chiorazzi Alessia,Carozzi Valentina A,Canta Annalisa,Sala Barbara,Colombo Matteo,Oggioni Norberto,Ceresa Cecilia,Foudah Dana,La Russa Federica,Miloso Mariarosaria,Nicolini Gabriella,Marmiroli Paola,Bennett David LH,Cavaletti Guido

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/cc.27476

Reference46 articles.

1. Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma

2. Bortezomib

3. Targeting the Ubiquitin+Proteasome System in Solid Tumors

4. Shared Principles in NF-κB Signaling

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuronal toxicity and recovery from early bortezomib-induced neuropathy: targeting the blood nerve barrier but not the dorsal root ganglion;2024-06-01

2. Bortezomib-induced peripheral neuropathy: Clinical features, molecular basis, and therapeutic approach;Critical Reviews in Oncology/Hematology;2024-05

3. Recent advances in the treatment and prevention of peripheral neuropathy after multiple myeloma treatment;Ibrain;2023-09-06

4. The three pillars in treating antibody-mediated encephalitis;Wiener klinische Wochenschrift;2023-06-06

5. Bortezomib Pharmacogenetic Biomarkers for the Treatment of Multiple Myeloma: Review and Future Perspectives;Journal of Personalized Medicine;2023-04-20